Triamterene and Hydrochlorothiazide
NDC 68001-387, Triamterene and Hydrochlorothiazide, tablet, from BluePoint Laboratories.
- Product NDC
- 68001-387
- Status
- Listed
- Labeler
- BluePoint Laboratories
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA073449
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68001-387 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRIAMTERENE37.5 mg/1
- HYDROCHLOROTHIAZIDE25 mg/1
Pharmacologic classes
Decreased Renal K+ Excretion [PE]; Increased Diuresis [PE]; Increased Diuresis [PE]; Potassium-sparing Diuretic [EPC]; Thiazide Diuretic [EPC]; Thiazides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68001-387-03 | 68001038703 | 500 TABLET in 1 BOTTLE, PLASTIC (68001-387-03) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b8a55c23-b509-4790-88fa-9dc9bacd4bbe
Use it
Look up 68001-387 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68001-387 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68001-387. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.